Chronic hepatitis C trial initiated in Mexico using Interferon Sciences' natural-source alpha interferon.NEW BRUNSWICK, N.J.--(HealthWire)--July 8, 1996--Interferon IFN Sciences Inc. (ISI) (Nasdaq:IFSC IFSC - International Fuzzy Systems Conference Any of a group of glycoproteins that are produced by different cell types in response to various stimuli, such as exposure to viruses, and that block viral replication in newly infected cells and, in some cases, modulate specific cellular functions. IFSC - Irish Financial Services Centre) announced today that its licensee, Industria Farmaceutica Andromaco (Andromaco), has commenced a clinical trial in Mexico utilizing ISI's injectable formulation of Interferon Alfa-n3, the Company's highly purified, multispecies, natural-source alpha interferon, for the treatment of patients infected with chronic hepatitis C virus. This study is sponsored by Andromaco under both U.S. and Mexican Investigational New Drug (IND) applications, and is being conducted at the National Institute of Nutrition in Mexico City. Patients in this study are treated using a different treatment schedule and frequency from that used in previous trials conducted by ISI on patients infected with chronic hepatitis C virus. The results of this trial will provide information to help evaluate the safety and efficacy of this altered treatment regimen. In February 1994, ISI entered into a distribution agreement with Andromaco in Mexico for its Interferon Alfa-n3 injectable product. Andromaco, a privately-held pharmaceutical company which specializes in oncology and immunology products, has obtained approval from Mexican regulatory authorities to sell this product in Mexico for the treatment of warts WARTS - Wisconsin Architectural Research Tool Set anatomical wart tuberculosis verrucosa cutis. flat wart a small, smooth, usually skin-colored or light brown, slightly raised wart sometimes occurring in great numbers; seen most often in children. genital wart condyloma acuminatum. juvenile wart flat w. ">genital warts genital warts: see human papillomavirus., and is marketing the product under the trade name ALTEMOL(R). Interferon Sciences Inc. is a biopharmaceutical company engaged in the study, manufacture and sale of pharmaceutical products based on its highly purified, multispecies, natural-source alpha interferon. The Company's ALFERON(R) N Injection product has been approved by the United States Food and Drug Administration for the treatment of certain types of genital warts, and is being studied for the potential treatment of HIV, hepatitis C and other indications. The Company also has other natural-source alpha interferon formulations in various stages of development for the potential treatment of viral and immune system diseases and cancer. CONTACT: Interferon Sciences Inc., New Brunswick Lawrence M. Gordon, Chief Executive Officer, 908/249-3250, ext. 545 Stanley G. Schutzbank, Ph.D., President, 908/249-3250, ext. 502 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion